BUSATO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 116
EU - Europa 107
AS - Asia 59
OC - Oceania 2
SA - Sud America 1
Totale 285
Nazione #
US - Stati Uniti d'America 115
IT - Italia 69
SE - Svezia 18
SG - Singapore 18
HK - Hong Kong 17
CN - Cina 9
IE - Irlanda 8
IN - India 8
DE - Germania 5
PH - Filippine 3
AU - Australia 2
GB - Regno Unito 2
IR - Iran 2
VN - Vietnam 2
AT - Austria 1
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
CL - Cile 1
FR - Francia 1
NL - Olanda 1
Totale 285
Città #
Chandler 36
Trieste 23
Hong Kong 16
Singapore 12
Omaha 9
Redmond 7
Princeton 6
Andover 5
Ashburn 5
Dublin 5
Beijing 4
Cagliari 4
Montereale Valcellina 4
Raurkela 4
Viareggio 4
Los Angeles 3
Padova 3
Plaridel 3
Wilmington 3
Azzano Decimo 2
Bhubaneswar 2
Brisbane 2
Chicago 2
Dong Ket 2
Gardena 2
Hamburg 2
Medford 2
Mount Vernon 2
Qingdao 2
Turin 2
Vaxjo 2
Amsterdam 1
Bern 1
Boardman 1
Boydton 1
Coimbatore 1
Council Bluffs 1
Fairfield 1
Frankfurt am Main 1
London 1
New Delhi 1
Rome 1
Santiago 1
Seattle 1
Sofia 1
Toronto 1
Udine 1
Vicenza 1
Vienna 1
Totale 198
Nome #
Glypican 1-targeted therapeutic approaches adopting doxorubicin-loaded chitosan nanobubbles and antibody-based strategy in the context of Pancreatic Ductal Adenocarcinoma 119
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies 55
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients 54
New insight into therapies targeting angiogenesis in hepatocellular carcinoma 54
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 15
Totale 297
Categoria #
all - tutte 1.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/202243 3 0 3 0 0 0 0 1 1 1 1 33
2022/2023115 4 12 5 13 18 18 0 16 17 4 3 5
2023/202498 17 6 5 4 4 10 17 18 1 6 10 0
2024/202530 9 10 11 0 0 0 0 0 0 0 0 0
Totale 297